Over the past three months, six analysts have evaluated Praxis Precision Medicine (NASDAQ:PRAX), with opinions ranging from bullish to somewhat bullish. The average 12-month price target is $159.83, with a high of $270.00 and a low of $105.00. The company's financial performance shows challenges in revenue growth and returns on equity and assets, but it maintains a strong net margin and low debt-to-equity ratio.